Alimera Sciences Inc. (ALIM)
NASDAQ: ALIM
· Real-Time Price · USD
5.54
-0.01 (-0.18%)
At close: Sep 13, 2024, 10:00 PM
Alimera Sciences Revenue Breakdown
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|
| International Segment Revenue | 24.04M | 19.93M | 32.29M | 26.01M | 21.66M | 14.63M | 9.77M | 8.57M | 7.27M |
| International Segment Revenue Growth | +20.66% | -38.29% | +24.14% | +20.09% | +48.02% | +49.84% | +13.98% | +17.89% | n/a |
| United States Segment Revenue | 56.71M | 34.2M | 26.74M | 24.81M | 32.28M | 32.34M | 26.15M | 25.77M | 15.17M |
| United States Segment Revenue Growth | +65.81% | +27.91% | +7.78% | -23.15% | -0.17% | +23.68% | +1.48% | +69.84% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 15.88M | 14.51M | 14.15M | 11.55M | 10.81M | 9.97M | 9.1M | 9.86M | 9.81M | 10.09M | 10.37M | 8.56M | 8.69M | 8.23M | 8.44M | 7.38M | 7.36M | 8.85M | 10.31M | 9.56M | 9.78M | 9.31M | 10.14M | 8.93M | 9.15M | 9.82M | 10.09M | 9.32M | 8.07M | 8.77M | 11.54M | 11.1M | 11.55M | 10.5M | 10.81M | 9.98M | 10.75M | 10.75M |
| Selling, General, and Administrative Revenue Growth | +9.38% | +2.59% | +22.52% | +6.85% | +8.34% | +9.63% | -7.68% | +0.47% | -2.80% | -2.63% | +21.11% | -1.47% | +5.54% | -2.51% | +14.36% | +0.35% | -16.90% | -14.14% | +7.88% | -2.30% | +5.13% | -8.20% | +13.57% | -2.50% | -6.81% | -2.63% | +8.23% | +15.49% | -7.92% | -24.06% | +4.03% | -3.91% | +9.95% | -2.79% | +8.28% | -7.13% | -0.02% | n/a |
| Research and Development Revenue | 4.26M | 4.36M | 4.77M | 4.04M | 3.65M | 4.16M | 4.23M | 4.48M | 3.93M | 3.58M | 3.72M | 3.28M | 3.57M | 3.21M | 2.51M | 2.47M | 1.81M | 2.88M | 2.67M | 2.76M | 2.83M | 2.73M | 2.88M | 2.8M | 2.78M | 2.82M | 3.08M | 3.3M | 2.24M | 2.11M | 2.89M | 3.26M | 3.21M | 3.02M | 3.62M | 4.08M | 3.81M | 3.33M |
| Research and Development Revenue Growth | -2.25% | -8.56% | +17.90% | +10.88% | -12.39% | -1.56% | -5.64% | +14.01% | +9.74% | -3.68% | +13.48% | -8.10% | +11.02% | +28.21% | +1.50% | +36.41% | -37.22% | +7.98% | -3.30% | -2.58% | +3.92% | -5.18% | +2.75% | +0.79% | -1.59% | -8.26% | -6.76% | +47.41% | +6.07% | -26.96% | -11.41% | +1.75% | +6.13% | -16.53% | -11.28% | +6.89% | +14.60% | n/a |
| Sales and Marketing Revenue | 8.51M | 9.08M | 7.77M | 7.94M | 6.43M | 5.8M | 5.76M | 6.5M | 6.87M | 6.85M | 7.17M | 5.75M | 5.33M | 4.82M | 4.99M | 4.76M | 4.38M | 5.67M | 6.55M | 6.44M | 6.11M | 5.91M | 6.14M | 5.48M | 5.93M | 5.97M | 6.65M | 6M | 5.06M | 5.5M | 7.36M | 7.45M | 7.51M | 7.11M | 7.09M | 6.95M | 6.92M | 7.13M |
| Sales and Marketing Revenue Growth | -6.29% | +16.92% | -2.17% | +23.41% | +10.85% | +0.68% | -11.36% | -5.26% | +0.18% | -4.41% | +24.66% | +7.88% | +10.65% | -3.35% | +4.64% | +8.72% | -22.74% | -13.35% | +1.69% | +5.39% | +3.30% | -3.73% | +12.08% | -7.53% | -0.72% | -10.19% | +10.73% | +18.62% | -8.03% | -25.24% | -1.23% | -0.77% | +5.64% | +0.31% | +1.99% | +0.35% | -2.86% | n/a |